GYRE
GYRE THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$4.44
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 2.47x
- P/S forward
- 15.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.61x
- Price / sales
- 3.94x
- Price / cash flow
- -32.47x
Enterprise value
- Enterprise value
- $456.4M
- EV / sales
- 3.82x
- EV / EBITDA
- -36.20x
- EV / EBIT
- -27.37x
- Market cap
- $470.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026